EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

HUMAN BRUCELLOSIS; A PHYSICIAN’S EXPERIENCE OVER 12 YEARS

Mallikarjuna Shetty*, Adiraju Krishna Prasad and Nageswar Rao Modugu

ABSTRACT

Introduction; Brucellosis is the commonest zoonosis all over the world. with varied presentation involving multiple organs with misdiagnosis and treatment. Aim: To study the clinical features, laboratory investigations, complications and treatment outcome in patients with Brucellosis. Material and methods: We retrospectively collected data from case records of patients with Brucellosis over 2005 to 2016 (12 years) and the parameters studied were Age, symptoms, signs, investigations specially Blood and bonemarrow serology for brucellosis along with blood and bonemarrow cultures for brucellosis along with treatment outcome. Results: Total number of patients were 13 with Male to female ratio of 6:7, and mean age was43.15 years, the commonest occupation was house wife and the symptom was fever in100% with average duration of 96.3 days, followed by joint pains in 61%, with hepatospleenomagely in7.6% patients. Pallor was present in 15.2% patients with average ESR of 103.66mm1st hour, Obstructive hepatopathy in 46% patients, Brucella serology positivety in blood was seen in all patients except 1, with titres of 1:160 in46% 1:320 in7.6%, 1:640 and 1:1280 in15.2% patients, Bonemarrow positive serology for Brucella was seen in 10 patients with titres of 1:160 in7.6%,1:320in15.2%,1:640 in23%,1:1280 in23% patients. And 30.76% patients had grown Brucella on blood culture and 23% had grown Brucella by bonemarrow culture. All the patient responded to the treatment, except 1 patient mortality due to multiorgan involment. Conclusion: Brucellosis still remains a challenging disease for physicians with different presentations. Its important to diagnose and treat early to prevent morbidity and mortality.

Keywords: Blood serology, Bone marrowculture, Doxcycline, Fever, Rifampicin, Streptomycin.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )